Can You Take Ketamine While on Antidepressants?

Ketamine is used alongside antidepressants routinely, and in fact the FDA-approved nasal spray form (esketamine, sold as Spravato) is specifically labeled as an add-on to an oral antidepressant rather than a standalone treatment. That said, the answer depends heavily on which antidepressant you are taking. Some combinations are well-supported by large studies, others appear safe but may blunt ketamine’s benefits, and at least one pairing raises genuine safety concerns that clinicians watch closely.

Why Ketamine and Traditional Antidepressants Generally Do Not Clash

Most antidepressants work by increasing the availability of serotonin, norepinephrine, or both in the brain. Ketamine operates through an entirely different channel. Its primary action involves blocking a receptor called NMDA and boosting activity at another receptor called AMPA, both of which are part of the glutamate system. That downstream activity triggers the growth of new neural connections, which is thought to explain why ketamine can improve depression symptoms within hours rather than the weeks conventional antidepressants typically require.¹ Because the two drug classes largely act on separate neurochemical systems, combining them does not usually produce the kind of dangerous overlap that, say, mixing two serotonin-boosting drugs can.

That separation is the reason esketamine was developed and approved as an add-on therapy. Clinical trials and regulatory submissions in the United States, the European Union, and Japan have all evaluated esketamine specifically in patients who are already taking an oral antidepressant.² The regulatory assumption, backed by trial data, is that the combination is manageable under clinical supervision.

SSRIs and SNRIs Are the Best-Studied Partners

If you take an SSRI like sertraline, fluoxetine, or escitalopram, or an SNRI like venlafaxine or duloxetine, the evidence is relatively reassuring. A large population-based study looked at nearly 56,000 adults with treatment-resistant depression who received esketamine alongside either an SSRI or an SNRI. Across both groups, rates of death, hospitalization, depression relapse, and suicide attempts were low throughout the study period.³

An interesting wrinkle in that study was that outcomes were not identical between the two classes. Patients receiving esketamine alongside an SNRI had lower rates of death, hospitalization, and depression relapse than those paired with an SSRI. The SSRI group, however, had slightly fewer suicide attempts. The differences were statistically significant, though the absolute numbers in each category were small.³ This does not mean one class is clearly better; the study design could not fully control for why a patient was on an SSRI versus an SNRI in the first place. But it does suggest that these pairings are not interchangeable, and that your clinician may have reason to prefer one over the other.

MAOIs Require the Most Caution

Monoamine oxidase inhibitors, the oldest class of antidepressants, are the combination that raises the most red flags. The concern is twofold: MAOIs can amplify the blood-pressure-raising effects of ketamine, and the combination carries a theoretical risk of serotonin syndrome, a potentially dangerous condition caused by too much serotonin activity in the brain.

A systematic review and case series specifically examined what happens when ketamine is added to an MAOI regimen. Blood pressure and heart rate did go up in several cases, though the elevations were judged clinically insignificant in all but one patient. No cases of serotonin syndrome or hypertensive crisis were observed.⁴ The researchers concluded that the combination may be less dangerous than traditionally assumed, but the evidence base remains thin. Most clinicians still treat this pairing with considerable caution, and some ketamine clinics will not administer ketamine to patients on an MAOI without additional monitoring or a washout period.

Ketamine’s Indirect Serotonin Effects

Even though ketamine’s primary target is the glutamate system, it does have a secondary effect on serotonin. When ketamine boosts AMPA receptor activity in the prefrontal cortex, that triggers a downstream release of serotonin.⁵ For most people on a standard SSRI or SNRI, this added serotonin nudge does not push things into dangerous territory. But it does mean ketamine is not serotonin-neutral. In patients already on multiple serotonergic medications, or in settings like electroconvulsive therapy where ketamine is sometimes used as an anesthetic, the cumulative serotonin load can occasionally tip over into serotonin syndrome.

This is one reason why ketamine treatment in a clinical setting involves monitoring vital signs and watching for symptoms like agitation, rapid heart rate, muscle rigidity, and elevated body temperature. Your prescriber needs a full picture of everything you are taking, including supplements and over-the-counter products that affect serotonin.

Benzodiazepines Can Weaken Ketamine’s Antidepressant Effect

Benzodiazepines are not antidepressants, but they are prescribed so commonly alongside antidepressants for anxiety and insomnia that any discussion of ketamine drug interactions would be incomplete without them. The evidence here is consistent: benzodiazepines can blunt how well ketamine works for depression.

A systematic review of pharmacodynamic interactions found that benzodiazepines repeatedly shortened the duration of ketamine’s antidepressant effect.⁶ A study from the RAPID Intravenous Ketamine trial added more detail: whether you were simply on a benzodiazepine did not by itself predict a weaker ketamine response, but taking a higher dose of a benzodiazepine was associated with less improvement in depression scores 24 hours after the infusion. By day three, the dampening effect had faded.⁷

This matters practically because benzodiazepines work on the GABA system, which broadly has an inhibitory effect in the brain. Ketamine’s antidepressant action depends on ramping up glutamate-driven neural activity, and GABA essentially applies the brakes on that process. If you take a benzodiazepine regularly, your clinician may suggest holding or reducing the dose around ketamine treatments, though that decision always has to be balanced against the risk of rebound anxiety or withdrawal.

Lamotrigine Reduces Side Effects but Adds a Complication

Lamotrigine is a mood stabilizer that works in part by dampening glutamate release, which puts it in a unique position relative to ketamine. A controlled study in healthy volunteers found that lamotrigine significantly reduced many of ketamine’s unwanted neuropsychiatric effects, including dissociation, perceptual disturbances, and memory impairment. But it also enhanced ketamine’s immediate mood-elevating effects.⁸

That sounds like a win on both fronts, but there is a complication. Lamotrigine reduces the glutamate surge that ketamine produces, and that surge appears to be part of how ketamine works as an antidepressant. The worry is that by smoothing out the acute side effects, lamotrigine may also be trimming away some of the therapeutic mechanism. Research has not conclusively settled whether this trade-off matters in practice for depression outcomes. If you are on lamotrigine for bipolar disorder and considering ketamine, your provider will likely weigh the reduced side-effect profile against the possibility of a weaker or shorter antidepressant response.

How Other Medications Change Ketamine Levels in Your Body

Ketamine is broken down in the liver by a set of enzymes, particularly CYP2B6 and CYP3A4. Many psychiatric medications either speed up or slow down these same enzymes, which means they can change how much ketamine actually circulates in your bloodstream and for how long.⁹ Drugs that inhibit these enzymes push ketamine levels higher than expected; drugs that rev the enzymes up cause ketamine to be cleared faster, potentially making a dose less effective.

This gets especially relevant when a patient is on multiple psychiatric medications, each of which may be a substrate for the same enzymes. A review examining pharmacogenetic and drug-interaction factors in ketamine therapy emphasized that the overlap between ketamine’s metabolic pathway and those of common antidepressants creates real potential for drug-drug interactions that affect dosing.¹⁰ Genetic variation in these enzymes adds another layer; some people metabolize ketamine unusually fast or slow regardless of what other drugs they take.

One particularly striking example comes from St. John’s wort, an herbal supplement many people take as a natural antidepressant. St. John’s wort is a potent inducer of CYP3A4. In a pharmacokinetic study, it reduced blood levels of oral S-ketamine by about 58 percent and cut peak concentrations by about two-thirds.¹¹ At that level of reduction, a standard ketamine dose might simply not work. If you are taking St. John’s wort and considering ketamine treatment, this is something to disclose to your provider, because many people do not think to mention herbal supplements.

Lithium and Antipsychotics

Lithium is sometimes used as a maintenance treatment after a ketamine response, with the reasoning that it shares some downstream neuroplasticity pathways and might help sustain the antidepressant effect. A randomized controlled trial tested this directly, assigning patients who had responded to ketamine to either daily lithium or a placebo. There was no difference in depression severity between the two groups, and lithium did not extend ketamine’s antidepressant effect compared to placebo.¹² The combination did not appear unsafe, but it did not offer the synergy researchers had hoped for.

Antipsychotics present a different picture. A small but intriguing five-year follow-up study examined patients who received ketamine while also taking various antipsychotics. Among those on quetiapine specifically, the time before depression relapsed was dramatically longer than in patients on other antipsychotics.¹³ The sample was tiny (five patients on quetiapine), so the finding is more hypothesis-generating than conclusive, but it has caught the attention of researchers interested in how to make ketamine’s benefits last longer.

Does Ketamine Work Just as Well Without an Antidepressant?

Most ketamine research has studied the drug as an addition to existing antidepressant therapy, which makes it hard to know how much the background medication contributed. A real-world study from a Canadian treatment center compared patients who received ketamine as monotherapy (no other antidepressant) with those who received it alongside their existing medications. Both groups showed significant improvements in depression. On most measures the two groups looked similar, though the monotherapy group had a slightly greater reduction in suicidal ideation and a higher proportion of partial responders after four infusions.¹⁴

That does not mean stopping your antidepressant before ketamine is a good idea. The people receiving monotherapy in this study were not randomly assigned to go medication-free; many had already discontinued their antidepressants due to side effects or lack of response. Stopping an antidepressant abruptly carries its own risks, including withdrawal symptoms and a rebound in depression. The practical takeaway is that if you happen to not be on an antidepressant for other reasons, ketamine can still work. But if you are on one, there is no evidence that you need to stop it first.

What Your Clinician Actually Needs to Know

The conversation before starting ketamine treatment should include every medication you take, not just prescription antidepressants. Herbal supplements like St. John’s wort can slash ketamine’s blood levels enough to make a session ineffective. Benzodiazepines at higher doses may dampen the antidepressant response in the short term. MAOIs remain the one class where extra vigilance around blood pressure and serotonin symptoms is warranted. And the liver enzymes that break down ketamine are shared by a long list of psychiatric and non-psychiatric drugs, meaning unexpected interactions can come from medications you would not think to flag.

Genetic variation in those enzymes adds a wildcard. Some people metabolize ketamine unusually quickly and may need dose adjustments; others clear it slowly and may experience stronger effects or more side effects at a standard dose.¹⁰ Pharmacogenomic testing is available but not yet routine in most ketamine clinics. As the field matures and more data accumulate on drug interactions in real-world patients, dosing protocols will likely become more individualized. For now, the most important thing you can do is give your provider a complete and honest medication list, including anything you buy at a health food store.